SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioVal Analysis Covers SynAct’s Resomelagon Across Three Indications

A BioVal analysis covers SynAct’s resomelagon across three indications.

Related stories